Get the Stockscreener App
19.11
2.70%
-0.53
Shoulder Innovations Inc stock is traded at $19.11, with a volume of 79,913.
It is down -2.70% in the last 24 hours and down -7.90% over the past month.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
See More
Previous Close:
$19.64
Open:
$19.64
24h Volume:
79,913
Relative Volume:
0.65
Market Cap:
$397.85M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-0.6379
EPS:
-29.96
Net Cash Flow:
-
1W Performance:
-6.28%
1M Performance:
-7.90%
6M Performance:
+46.44%
1Y Performance:
+50.00%
1-Day Range:
$19.09
$20.45
1-Week Range:
$19.09
$20.84
52-Week Range:
$10.92
$24.59
Shoulder Innovations Inc Stock (SI) Company Profile
Name
Shoulder Innovations Inc
Sector
Industry
Phone
616-566-0286
Address
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
19.11 | 397.85M | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
103.36 | 178.85B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.19B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 103.57B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 62.46B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 50.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | BTIG Research | Buy |
| Aug-25-25 | Initiated | Goldman | Buy |
| Aug-25-25 | Initiated | Jefferies | Buy |
| Aug-25-25 | Initiated | Piper Sandler | Overweight |
| Mar-06-23 | Downgrade | Compass Point | Neutral → Sell |
| Mar-06-23 | Downgrade | Wedbush | Neutral → Underperform |
| Mar-02-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-23 | Downgrade | Compass Point | Buy → Neutral |
| Mar-02-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-01-23 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jan-06-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-06-23 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-12-22 | Reiterated | Wedbush | Outperform |
| Dec-05-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-21-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-10-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-22 | Downgrade | Goldman | Buy → Neutral |
| Oct-06-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Aug-04-22 | Initiated | BTIG Research | Buy |
| Jun-13-22 | Initiated | Wells Fargo | Overweight |
| Jun-09-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-21-22 | Initiated | BofA Securities | Buy |
| Jan-20-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-16-21 | Initiated | B. Riley Securities | Buy |
| Nov-11-21 | Initiated | JP Morgan | Overweight |
| Nov-08-21 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Sep-27-21 | Initiated | Morgan Stanley | Overweight |
| Jun-14-21 | Initiated | Goldman | Neutral |
| Jan-14-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-22-20 | Initiated | Wedbush | Outperform |
| Dec-17-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Dec-02-20 | Initiated | Craig Hallum | Buy |
| Oct-16-20 | Initiated | Compass Point | Buy |
| Mar-16-20 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | Keefe Bruyette | Mkt Perform |
| Dec-02-19 | Initiated | Barclays | Overweight |
| Nov-18-19 | Initiated | Compass Point | Buy |
View All
Shoulder Innovations Inc Stock (SI) Latest News
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com Canada
Shoulder Innovations receives FDA clearance for titanium implant - Investing.com
Shoulder Innovations Receives FDA 510(K) Clearance For N-22 Humeral Head And Initiates Full Commercial Launch - TradingView
About 10% to 15% of people test positive for metal sensitivity. Shoulder Innovations launches an implant. - Stock Titan
Shoulder Innovations partners with ALM Ortho on implants - Investing.com
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - STLtoday.com
Catalyst OrthoScience Announces Settlement of Patent Litigation with Shoulder Innovations - Business Wire
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience - Ortho Spine News
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com India
Shoulder Innovations Settles Patent Dispute With Catalyst OrthoScience - marketscreener.com
Shoulder Innovations settles patent dispute with Catalyst - Investing.com
Shoulder Innovations Announces Settlement of - Moomoo
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference - Morningstar
Shoulder Innovations to present at Morgan Stanl... - Pluang
Morgan Stanley healthcare conference sets Sept. 15 chat with Shoulder Innovations - Stock Titan
Shoulder Innovations (SI) holder trims stake with 1,196-share sale - Stock Titan
Gilde Healthcare holding B.V. sells $567k in Shoulder Innovations stock - Investing.com Nigeria
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook - Eastern Progress
Shoulder (SI) Financial Results: Profit Per Share Clears Its Benchmark; Market Response: Shares Close 0.18% Lower in the Latest ReadingEarnings Whisper Number - vinanet.vn
Shoulder (SI) Earnings Snapshot: The Bottom-Line Figure Beats Its Comparison in Latest Trading; Closing Move: Shares Finish 4.99% LowerEarnings Decline Risk - vinanet.vn
Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 8,314 Shares of Stock - MarketBeat
Shoulder Innovations (SI) COO sells shares under 10b5-1 plan - Stock Titan
Shoulder Innovations (NYSE: SI) plans 22,500-share sale - Stock Titan
Gilde Healthcare sells $213,479 of Shoulder Innovations stock - Investing.com
Gilde Healthcare sells $213,479 of Shoulder Innovations stock By Investing.com - Investing.com UK
SHOULDER INNOVATIONS, INC. SEC Filing (Aug 14, 2026) - Stock Titan
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer - AOL.com
Shoulder Innovations Inc (SI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Shoulder Innovations at Canaccord Genuity conference: growth, margins rise By Investing.com - Investing.com Canada
Shoulder Innovations at Canaccord Genuity conference: growth, margins rise - Investing.com
Shoulder Innovations announces $4.9M expansion to Byron Center, creating 42 new jobs - FOX 17 West Michigan News
SHOULDER INNOVATIONS, INC. : UBS RAISES TARGET PRICE TO $28 FROM $27 - webull.com
Medical technology company plans new headquarters in Byron Township - Yahoo
Shoulder Innovations elevates Jon Osborne to CCO - medicalbuyer.co.in
Shoulder Innovations, Inc. (NYSE:SI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Shoulder Innovations (SI) CCO Jonathan Osborne reports stock and option stakes - Stock Titan
Shoulder Innovations, Inc. Announces Appointment of Jon Osborne to Chief Commercial Officer, Effective August 6, 2026 - marketscreener.com
Grand Rapids medtech firm raises 2026 forecast as sales surge 56% - Crain's Grand Rapids Business
Jon Osborne Appointed Chief Commercial Officer at Shoulder Innovations - Kalkine Media
UBS Adjusts Shoulder Innovations Price Target to $28 From $27, Maintains Buy Rating - marketscreener.com
Shoulder Innovations promotes Jon Osborne to commercial chief By Investing.com - Investing.com Australia
Shoulder Innovations promotes Jon Osborne to commercial chief - Investing.com
Shoulder Innovations Promotes Jon Osborne to Commercial Chief - TipRanks
Shoulder Innovations Q2 Earnings Call Highlights - sharewise.com
Major Investor Makes Bold Move in Shoulder Innovations, Inc. Shake-Up - TipRanks
Shoulder Innovations (NYSE:SI) Major Shareholder Sells $166,132.32 in Stock - MarketBeat
Shoulder Innovations (NYSE:SI) Major Shareholder Sells $47,347.00 in Stock - MarketBeat
Shoulder Innovations (SI): Gilde Healthcare sells shares, holds 10.7% stake - Stock Titan
Shoulder Innovations (SI) 10% holder sells 9,433 shares - Stock Titan
Piper Sandler Reiterates "Overweight" Rating for Shoulder Innovations (NYSE:SI) - MarketBeat
BTIG Research Increases Shoulder Innovations (NYSE:SI) Price Target to $26.00 - MarketBeat
Shoulder Innovations Inc Stock (SI) Financials Data
There is no financial data for Shoulder Innovations Inc (SI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):